OCMI

Oaktop Capital Management II Portfolio holdings

AUM $930M
This Quarter Return
+19.06%
1 Year Return
+12.03%
3 Year Return
+128.14%
5 Year Return
+269.31%
10 Year Return
+745.39%
AUM
$648M
AUM Growth
+$648M
Cap. Flow
-$16.3M
Cap. Flow %
-2.51%
Top 10 Hldgs %
93.08%
Holding
19
New
Increased
Reduced
2
Closed
3

Top Buys

No buys this quarter

Sector Composition

1 Technology 71.13%
2 Industrials 9.22%
3 Healthcare 8.43%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
LRCX icon
1
Lam Research
LRCX
$127B
$176M 27.1%
295,254
-21,250
-7% -$12.6M
KLAC icon
2
KLA
KLAC
$115B
$132M 20.42%
400,750
MXIM
3
DELISTED
Maxim Integrated Products
MXIM
$67.8M 10.46%
742,375
ASPN icon
4
Aspen Aerogels
ASPN
$563M
$59.8M 9.22%
2,939,758
BMY icon
5
Bristol-Myers Squibb
BMY
$96B
$42.9M 6.62%
679,991
CEVA icon
6
CEVA Inc
CEVA
$531M
$35.5M 5.47%
631,377
PRGS icon
7
Progress Software
PRGS
$2B
$27M 4.16%
612,526
SONO icon
8
Sonos
SONO
$1.68B
$24.4M 3.76%
650,000
EGAN icon
9
eGain
EGAN
$172M
$24.1M 3.71%
2,536,843
VMW
10
DELISTED
VMware, Inc
VMW
$13.9M 2.15%
92,500
DELL icon
11
Dell
DELL
$82.6B
$12.4M 1.91%
140,619
PETS icon
12
PetMed Express
PETS
$63.4M
$11.7M 1.81%
333,675
-40,000
-11% -$1.41M
AVGO icon
13
Broadcom
AVGO
$1.4T
$7.42M 1.14%
16,000
GRMN icon
14
Garmin
GRMN
$46.5B
$6.33M 0.98%
48,000
XLE icon
15
Energy Select Sector SPDR Fund
XLE
$27.6B
$4.91M 0.76%
100,000
INTC icon
16
Intel
INTC
$107B
$2.11M 0.33%
33,010
ANIK icon
17
Anika Therapeutics
ANIK
$135M
-12,500
Closed -$566K
AXDX
18
DELISTED
Accelerate Diagnostics
AXDX
-155,000
Closed -$1.18M
BMY.RT
19
DELISTED
Bristol-Myers Squibb Company Contingent Value Rights
BMY.RT
-704,991
Closed -$487K